← Back to Clinical Trials
Recruiting NCT05660460

NCT05660460 COPD at a Street Level

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05660460
Status Recruiting
Phase
Sponsor Hvidovre University Hospital
Condition COPD
Study Type INTERVENTIONAL
Enrollment 511 participants
Start Date 2023-03-15
Primary Completion 2027-03-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Spirometry

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 511 participants in total. It began in 2023-03-15 with a primary completion date of 2027-03-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The trial investigates and describes the prevalence of COPD among socially vulnerable individuals who come in contact with a mobile clinic and investigates the effect of opportunistic screening for COPD in these vulnerable persons. The study population is individuals who come in contact with a mobile clinic, that visits home shelters, open drugs scenes etc. in the Capital Region of Denmark during the inclusion period, and monitor them for up to 1 year in order to investigate variables that are significant in terms of the patients' treatment, hospitalizations, and mortality in relation to COPD. Our hypothesis is that there will be a higher incidence of COPD among socially vulnerable individuals who come in contact with the mobile clinic than in the general population.

Eligibility Criteria

Inclusion Criteria: * 18 years or older * Able to speak and understand Danish or English to such an extent that informed consent can be obtained Exclusion Criteria: \- Not having a Danish civil registration number, since foreign patients do not have free access to examinations and medical treatment, and cannot be followed up in the national patient registry

Contact & Investigator

Central Contact

Jannet van der Veen

✉ jannet@brugernesakademi.dk

📞 +45 21157392

Principal Investigator

Jannet van der Veen

STUDY CHAIR

Brugernes Akademi

Frequently Asked Questions

Who can join the NCT05660460 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05660460 currently recruiting?

Yes, NCT05660460 is actively recruiting participants. Contact the research team at jannet@brugernesakademi.dk for enrollment information.

Where is the NCT05660460 trial being conducted?

This trial is being conducted at Copenhagen, Denmark.

Who is sponsoring the NCT05660460 clinical trial?

NCT05660460 is sponsored by Hvidovre University Hospital. The principal investigator is Jannet van der Veen at Brugernes Akademi. The trial plans to enroll 511 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology